Abstract: The placenta has long been underappreciated and understudied by the scientific community. Improper function of this critical organ causes fetal abnormalities, premature labor and the most common disease of pregnancy, preeclampsia. Despite the importance of the placenta, our understanding of its role in fetal development, especially at a molecular level, is crude. Sadly, our understanding of placental function may be compared to the knowledge of kidney function 50 years ago-- we can describe the anatomy, but not the biology. My overarching goal is to use new molecular techniques to understand placental function and its relationship to fetal outcomes. Here my specific goal is to investigate how placental hormones shape fetal brain development. As an endocrine organ, the placenta produces a wide array of neuroactive hormones. This endocrine function can be disrupted in many ways- by abnormal gene expression, infection, prematurity- resulting in long-term damage. Preterm birth, affecting one tenth of all deliveries, provides the most extreme case of hormone loss, but I hypothesize that it is just one of many cases in which placental dysfunction leads to brain damage. I will develop a series of animals in which individual hormones are specifically removed from the placenta at precise times during development. This system will allow the first direct, definitive tests of the placenta as a key regulator of fetal brain development. Both established hormones, such as progestins and oxytocin, and hormones that we have recently identified as neuromodulators made by the placenta, such as secretin, will be assessed. These experiments are likely to provide fundamental new insights in placental physiology and neurodevelopment, help redefine disorders such as cerebral palsy, autism and schizophrenia as disorders of the placenta and open new avenues to theraputic treatments to improve neurological outcome in fetuses and infants at high risk of developmental brain damage. Public Health Relevance: The placenta is a vital component of healthy pregnancy and compromised placental function has been linked to diverse developmental disorders including cerebral palsy, autism and schizophrenia. The early loss of placental hormones due to preterm birth, which affects more than 400,000 infants in the United States each year, and poor placental function due to preeclampsia or infection, which accounts for the majority of pregnancy-related deaths worldwide, may underlie these developmental disorders. Understanding the role of placental hormones during pregnancy and brain development, as investigated by the experiments proposed here, can provide new approaches to treatments that can improve outcome in preterm infants and others at high risk of developmental brain damage.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
NIH Director’s New Innovator Awards (DP2)
Project #
1DP2OD006457-01
Application #
7848643
Study Section
Special Emphasis Panel (ZGM1-NDIA-O (02))
Program Officer
Basavappa, Ravi
Project Start
2009-09-30
Project End
2013-02-28
Budget Start
2009-09-30
Budget End
2013-02-28
Support Year
1
Fiscal Year
2009
Total Cost
$1,582,409
Indirect Cost
Name
Stanford University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Himoto, Yuki; Kido, Aki; Mogami, Haruta et al. (2016) Placental function assessed visually using half-Fourier acquisition single-shot turbo spin-echo (HASTE) magnetic resonance imaging. Placenta 39:55-60
Chisholm, Karen M; Heerema-McKenney, Amy; Tian, Lu et al. (2016) Correlation of preterm infant illness severity with placental histology. Placenta 39:61-9
Penn, Anna A; Gressens, Pierre; Fleiss, Bobbi et al. (2016) Controversies in preterm brain injury. Neurobiol Dis 92:90-101
Nelson, Karin B; Penn, Anna A (2015) Is infection a factor in neonatal encephalopathy? Arch Dis Child Fetal Neonatal Ed 100:F8-F10
Carson, Dean S; Howerton, Christopher L; Garner, Joseph P et al. (2014) Plasma vasopressin concentrations positively predict cerebrospinal fluid vasopressin concentrations in human neonates. Peptides 61:12-6
Clark, Catherine L; St John, Nicholas; Pasca, Anca M et al. (2013) Neonatal CSF oxytocin levels are associated with parent report of infant soothability and sociability. Psychoneuroendocrinology 38:1208-12
Lan, Wen-Chun J; Priestley, Matthew; Mayoral, Sonia R et al. (2011) Sex-specific cognitive deficits and regional brain volume loss in mice exposed to chronic, sublethal hypoxia. Pediatr Res 70:15-20
Knox, K; Leuenberger, D; Penn, A A et al. (2011) Global hormone profiling of murine placenta reveals Secretin expression. Placenta 32:811-6
Saria, Suchi; Rajani, Anand K; Gould, Jeffrey et al. (2010) Integration of early physiological responses predicts later illness severity in preterm infants. Sci Transl Med 2:48ra65
Mayoral, Sonia R; Omar, Ghezal; Penn, Anna A (2009) Sex differences in a hypoxia model of preterm brain damage. Pediatr Res 66:248-53